MELISSA ROSENHAN: Open Payments
NPI 1932680402 · SCARSDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 65 payments from 14 companies in 2025. Trend: 2023 $3,500 · 2024 $1,917 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 28 | $348 |
| PFIZER INC. | 8 | $135 |
| ABBVIE INC. | 4 | $109 |
| Janssen Biotech, Inc. | 5 | $99 |
| UCB, Inc. | 4 | $67 |
| GENZYME CORPORATION | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Amgen Inc. | 2 | $52 |
| Galderma Laboratories, L.P. | 2 | $42 |
Products named: OPZELURA, CIBINQO, SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, Rhapsido, OTEZLA.
Industry payments across NY — which companies pay providers there.
